Researchers at Oxford have discovered fresh evidence that the Shingrix vaccine could have a beneficial impact on heart health. The findings, published in *Nature Medicine*, suggest that individuals who received the Shingrix vaccine experienced a reduction of approximately ten percent in heart proble…
Researchers at Oxford have discovered fresh evidence that the Shingrix vaccine could have a beneficial impact on heart health. The findings, published in *Nature Medicine*, suggest that individuals who received the Shingrix vaccine experienced a reduction of approximately ten percent in heart problems over a seven-year period compared to those who had been immunized with an older, live vaccine. This decrease in cardiovascular disease risk was also observed in cases of coronary heart disease and heart failure. The study's authors estimate that, if replicated nationwide, this effect could translate to hundreds of thousands of avoided cases in the United States within a seven-year timeframe. While the study's results are significant, they fall short of the protective effects previously reported in observational studies, which ranged from twenty to thirty percent. The Oxford team's approach was designed to minimize bias by focusing solely on data from vaccinated individuals, all of whom had received either the old or the new vaccine between 2017 and 2018. By comparing patient records from over 70,000 Americans, the researchers were able to identify a correlation between Shingrix vaccination and improved heart health. According to Hugo Pedder, a statistician at the University of Bristol who was not involved in the study, this research is one of the most robust on the topic. However, further clinical trials would be necessary to confirm the findings. The study also sheds light on the potential mechanisms underlying Shingrix's effects, which may involve the vaccine's unique booster agent influencing immune system cells to reduce inflammatory reactions and protect the heart. Despite these promising results, much remains unclear, including the vaccine's impact on dementia. A previous study by the Oxford team found that individuals vaccinated with Shingrix developed dementia approximately half a year later than their peers who had received the older vaccine. Further research is needed to confirm these findings and fully understand the benefits of Shingrix vaccination.
